Skip to main content
. 2012 Jun 1;98(11):848–854. doi: 10.1136/heartjnl-2012-301629

Table 2.

Treatment during hospital stay and at discharge of the three patient groups

Normal glucose tolerance (n=78) Abnormal glucose tolerance (n=112) Diabetes mellitus (n=85) p Value
Thrombolysis 3 (4%) 3 (3%) 6 (7%) 0.32
Primary PCI
 POBA 22 (28%) 30 (27%) 17 (20%) 0.42
 Stents 45 (58%) 70 (63%) 51 (60%) 0.80
Aspirin 76 (97%) 110 (98%) 82 (96%) 0.74
Ticlopidine 44 (56%) 66 (59%) 48 (56%) 0.92
β-blockers 60 (77%) 95 (85%) 70 (82%) 0.38
ACE inhibitors 64 (82%) 89 (79%) 74 (87%) 0.38
Calcium channel blockers 14 (18%) 12 (11%) 14 (16%) 0.32
Diuretics 8 (10%) 12 (11%) 13 (15%) 0.53
Statin 20 (26%) 46 (41%) 24 (28%) 0.05
Oral hypoglycemic agents 0 (0%) 20 (18%) 66 (78%) <0.0001
Insulin therapy 0 (0%) 0 (0%) 6 (7%) 0.004

Data are n (%) unless otherwise indicated.

CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; POBA, plain old balloon angioplasty.